Clinical Trial Update: Cross-linked CMC and Silk Proteins in Eye Disease

View source ↗

Summary

Completed clinical trial evaluating a cross-linked carboxymethyl cellulose and silk protein ocular formulation for dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Cross-linked CMC and Silk Proteins ocular formulation (cross-linked carboxymethyl cellulose and silk protein hydrogel)

Snippet

Sponsor: D&V FARMA srl | Conditions: Dry Eye Disease (DED) | Status: COMPLETED